Challenges Associated With the Recent Outbreaks of Wild-Type Poliovirus in Previously Polio-Free Countries

Human Vaccines and Immunotherapeutics- United States

doi 10.4161/hv.22489

Full Text

Abstract

Available in

Date

January 1, 2013

Authors

Subhash C. Arya

Nirmala Agarwal

Publisher

Informa UK Limited

Related search

Intestinal Antibody Responses to a Live Oral Poliovirus Vaccine Challenge Among Adults Previously Immunized With Inactivated Polio Vaccine in Sweden

English

Persistence of Antibodies Against Diphtheria, Tetanus, Pertussis, and Poliovirus Types I, II, and III Following Immunization With DTaP Combined With Inactivated Wild-Type Polio Vaccine (DTaP-wIPV)

Japanese Journal of Infectious Diseases

English

Vaccine-Derived Poliovirus Surveillance in China During 2001–2013: The Potential Challenge for Maintaining Polio Free Status

BMC Infectious Diseases

Infectious Diseases

2017

English

Socioeconomic Status and Vaccine Coverage During Wild-Type Poliovirus Emergence in Israel

Epidemiology and Infection

Epidemiology

Infectious Diseases

2016

English

Molecular Characterization of a Wild Poliovirus Type 3 Epidemic in the Netherlands (1992 and 1993).

Journal of Clinical Microbiology

Microbiology

1995

English

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)

Epidemiology and Vaccine Prevention

2017

English

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

English

Prolonged Excretion of Type-2 Poliovirus From a Primary Immune Deficient Patient During the Transition to a Type-2 Poliovirus-Free World, Israel, 2016

English

First Report of a Persistent Oropharyngeal Infection of Type 2 Vaccine-Derived Poliovirus (iVDPV2) in a Primary Immune Deficient (PID) Patient After Eradication of Wild Type 2 Poliovirus

International Journal of Infectious Diseases

English

Amanote Research

Challenges Associated With the Recent Outbreaks of Wild-Type Poliovirus in Previously Polio-Free Countries

Human Vaccines and Immunotherapeutics- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Intestinal Antibody Responses to a Live Oral Poliovirus Vaccine Challenge Among Adults Previously Immunized With Inactivated Polio Vaccine in Sweden

Persistence of Antibodies Against Diphtheria, Tetanus, Pertussis, and Poliovirus Types I, II, and III Following Immunization With DTaP Combined With Inactivated Wild-Type Polio Vaccine (DTaP-wIPV)

Vaccine-Derived Poliovirus Surveillance in China During 2001–2013: The Potential Challenge for Maintaining Polio Free Status

Socioeconomic Status and Vaccine Coverage During Wild-Type Poliovirus Emergence in Israel

Molecular Characterization of a Wild Poliovirus Type 3 Epidemic in the Netherlands (1992 and 1993).

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

Prolonged Excretion of Type-2 Poliovirus From a Primary Immune Deficient Patient During the Transition to a Type-2 Poliovirus-Free World, Israel, 2016

First Report of a Persistent Oropharyngeal Infection of Type 2 Vaccine-Derived Poliovirus (iVDPV2) in a Primary Immune Deficient (PID) Patient After Eradication of Wild Type 2 Poliovirus